Maze Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Maze Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MAZE

Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM diseases. Its pipeline includes the Compass platform, which allows it to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process to refer a variant functionalization. 

CEO
Jason V. Coloma
CEOJason V. Coloma
Employees
141
Employees141
Headquarters
San Francisco, California
HeadquartersSan Francisco, California
Founded
2017
Founded2017
Employees
141
Employees141

MAZE Key Statistics

Market cap
1.92B
Market cap1.92B
Price-Earnings ratio
-12.84
Price-Earnings ratio-12.84
Dividend yield
—
Dividend yield—
Average volume
470.25K
Average volume470.25K
High today
$35.00
High today$35.00
Low today
$32.42
Low today$32.42
Open price
$32.72
Open price$32.72
Volume
82.81K
Volume82.81K
52 Week high
$53.65
52 Week high$53.65
52 Week low
$21.95
52 Week low$21.95

Stock Snapshot

As of today, Maze Therapeutics(MAZE) shares are valued at $34.59. The company's market cap stands at 1.92B, with a P/E ratio of -12.84.

During the trading session on 2026-11-06, Maze Therapeutics(MAZE) shares reached a daily high of $35.00 and a low of $32.42. At a current price of $34.59, the stock is +6.7% higher than the low and still -1.2% under the high.

Trading activity shows a volume of 82.81K, compared to an average daily volume of 470.25K.

The stock's 52-week range extends from a low of $21.95 to a high of $53.65.

The stock's 52-week range extends from a low of $21.95 to a high of $53.65.

MAZE News

Investing.com 2d
Maze Therapeutics earnings in focus as kidney drug rivalry heats up - Investing.com

...

Maze Therapeutics earnings in focus as kidney drug rivalry heats up - Investing.com

Analyst ratings

100%

of 14 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own MAZE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.